Embryonal rhabdomyosarcoma of the adult prostate: case report and review.
Adult
Embryonal
Rhabdomyosarcoma
Treatment refractory
Journal
Urology case reports
ISSN: 2214-4420
Titre abrégé: Urol Case Rep
Pays: United States
ID NLM: 101626357
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
04
10
2021
revised:
18
11
2021
accepted:
21
11
2021
entrez:
13
12
2021
pubmed:
14
12
2021
medline:
14
12
2021
Statut:
epublish
Résumé
Herein is reported a case of embryonal rhabdomyosarcoma of the prostate in a 54-year-old male. The presenting symptoms were dysuria, hematuria, and systemic thrombotic events. Diagnosis was ascertained through a transurethral resection. The treatment course consisted of transurethral resection, prostatic embolization, chemotherapy with dactinomycin, vincristine, and cyclophosphamide, cystoprostatectomy, rectal excision, and external beam radiation. The patient succumbed to the fatality of this disease within six months of diagnosis. Rhabdomyosarcoma is a rare tumor that can arise in the prostate and this case highlights an unusually refractory and rapidly fatal case. Treatment guidelines are not established for adults with this disease.
Identifiants
pubmed: 34900598
doi: 10.1016/j.eucr.2021.101953
pii: S2214-4420(21)00393-4
pmc: PMC8640110
doi:
Types de publication
Case Reports
Langues
eng
Pagination
101953Informations de copyright
© 2021 The Authors. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
None.
Références
Urol Oncol. 2016 Feb;34(2):103-15
pubmed: 26519985
Diagn Pathol. 2016 Jun 29;11(1):56
pubmed: 27357857
Oncology. 2011;80(1-2):21-8
pubmed: 21606660
Ann Surg. 2001 Aug;234(2):215-23
pubmed: 11505068
Cancer. 2003 Aug 1;98(3):571-80
pubmed: 12879475